4
Changes in Ownership
Entrada Therapeutics, Inc. Filed Acc 0001689375-25-000013
President & COO gave up 5,144 shares (to pay taxes)
- President & COO acquired 60,800 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Dowden Nathan J President & COO | 2025-03-01 | Grant or award | +60,800 | 185,949 | D: show line 1 in the form | ||
| Dowden Nathan J President & COO | 2025-03-03 | Shares withheld for taxes | −5,144 | $11.68 | $60,075 | 180,805 | D: show line 2 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Dowden Nathan J President & COO | 2025-03-01 | Grant or award · Stock Option (Right to Buy) | +90,800 | 90,800 | D: show line 3 in the form |
Loading xslF345X05/wk-form4_1741125544.xml…